{"filing":{"accession_number":"0001493152-26-027307","cik":"0001335105","ticker":"LIXT","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","form":"8-K","filing_date":"2026-06-04","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226027307/form8-k.htm"},"events":[{"id":6933,"run_id":6079,"accession_number":"0001493152-26-027307","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses a registered direct offering of 2,366,503 common shares and 258,859 pre-funded warrants, generating approximately $16.6 million in gross proceeds. This is a classic dilutive equity issuance under Item 1.01 (Entry Into a Material Definitive Agreement), where the company sold registered securities to accredited investors at $6.31 per share. The pre-funded warrants are immediately exercisable at $0.0001, creating significant dilution potential for existing shareholders.","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","ticker":"LIXT","filing_date":"2026-06-04","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":4485,"accession_number":"0001493152-26-027307","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a registered direct offering of 2,366,503 common shares and 258,859 pre-funded warrants, generating approximately $16.6 million in gross proceeds. This is a classic dilutive equity issuance under Item 1.01 (Entry Into a Material Definitive Agreement), where the company sold registered securities to accredited investors at $6.31 per share. The pre-funded warrants are immediately exercisable at $0.0001, creating significant dilution potential for existing shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:22:42.423194+00:00","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","ticker":"LIXT","filing_date":"2026-06-04"}]}